Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
class C beta-lactamase
Overview
| Protein Change | Nucleotide Change | Mechanism | Organism | Resistance To | Database | Validation Status |
|---|---|---|---|---|---|---|
| T105A | - | more efficient carbapenem and cefepime hydrolysis | Pseudomonas aeruginosa | imipenem|ceftazidime|cefepimeceftazidime|aztreonam | Reslit | Candidate |
| G183D | - | decreased hydrolytic activity toward TZP and carbapenems, reduced susceptibility to inhibition by avibactam | Pseudomonas aeruginosa | ceftolozane tazobactam|ceftazidime avibactamceftolozane|ceftazidimeavibactam+4 more | Reslit | Candidate |
| P154L | - | enhanced cephalosporin resistance | Pseudomonas aeruginosa | cephalosporins|aztreonamceftazidime|ceftolozaneceftolozane tazobactam | Reslit | Candidate |
| E247K | - | reduced susceptibility to inhibition by avibactam | Pseudomonas aeruginosa | ceftolozane|ceftazidimeavibactam|tazobactamceftolozane+1 more | Reslit | Candidate |
| T96I | - | reduced susceptibility to inhibition by avibactam | Pseudomonas aeruginosa | ceftolozane|ceftazidimeavibactamceftolozane+1 more | Reslit | Candidate |
| F121L | - | enhanced cephalosporin resistance | Pseudomonas aeruginosa | ceftazidime|ceftolozaneceftolozane tazobactam | Reslit | Candidate |
| G222S | - | enhanced cephalosporin resistance | Pseudomonas aeruginosa | ceftazidime|ceftolozane | Reslit | Candidate |
| A201T | - | enhanced cephalosporin resistance | Pseudomonas aeruginosa | ceftazidime|ceftolozane | Reslit | Candidate |
| G214R | - | enhanced cephalosporin resistance | Pseudomonas aeruginosa | ceftazidime|ceftolozane | Reslit | Candidate |
| E219K | - | enhanced cephalosporin resistance | Pseudomonas aeruginosa | ceftazidime|ceftolozane | Reslit | Candidate |
| S273R | - | - | Escherichia coli | cefoxitin | Reslit | Candidate |
| A163T | - | - | Pseudomonas aeruginosa | ceftolozane tazobactam | Reslit | Candidate |
| A4379035T | - | - | Escherichia coli | ampicillin | Reslit | Candidate |
| A292V | - | increased resistance | Escherichia coli, E. coli | ceftazidime|cefepimecefepime | Reslit | Candidate |
| V318A | - | - | Enterobacter hormaechei | cefiderocol | Reslit | Candidate |
| P58S | - | - | Enterobacter hormaechei | cefiderocol | Reslit | Candidate |
| T70I | - | - | Pseudomonas aeruginosa | ceftolozane tazobactam | Reslit | Candidate |
| G157D | - | - | Pseudomonas aeruginosa | ceftolozane tazobactam | Reslit | Candidate |
| P217Q | - | - | Pseudomonas aeruginosa | ceftolozane tazobactam | Reslit | Candidate |
| E221K | - | - | Pseudomonas aeruginosa | ceftolozane tazobactam | Reslit | Candidate |
| F147L | - | - | Pseudomonas aeruginosa | ceftolozane tazobactam|ceftazidime avibactamceftolozane | Reslit | Candidate |
| G183R | - | - | Pseudomonas aeruginosa | ceftolozane tazobactam|ceftazidime avibactam | Reslit | Candidate |
| R148W | - | increased resistance to ceftazidime/avibactam and cefepime | Klebsiella aerogenes | ceftazidime avibactam|cefepime | Reslit | Candidate |
| E247G | - | - | Pseudomonas aeruginosa | ceftolozane | Reslit | Candidate |
| S90A | - | The nonphosphorylatable mutant S90A was found to be more resistant to imipenem | Acinetobacter baumannii | imipenem | Reslit | Candidate |
| S90D | - | The phosphorylation-simulated mutant S90D was sensitive to imipenem | Acinetobacter baumannii | imipenem | Reslit | Candidate |
| Q86L | - | derepression of AmpC | Enterobacter cloacae | cefoxitin|cefotaxime|cefepime|ertapenem|imipenem|meropenem | Reslit | Candidate |
| G123D | - | - | E. coli | amoxicillin | Reslit | Candidate |
| S287N | - | increased resistance | E. coli | cefepime | Reslit | Candidate |
| S287C | - | increased resistance | E. coli | cefepime | Reslit | Candidate |
| H296P | - | increased resistance | E. coli | cefepime | Reslit | Candidate |
| V356I | - | - | Pseudomonas aeruginosa | ceftazidime|cefepime|ticarcillin|imipenempiperacillin tazobactam|ceftazidime | Reslit | Candidate |
| Q155I | - | - | Pseudomonas aeruginosa | ceftazidime|cefepime|ticarcillin|imipenem | Reslit | Candidate |
| E114A | - | - | Pseudomonas aeruginosa | ceftazidime|cefepime|ticarcillin|imipenem | Reslit | Candidate |
| V213A | - | increased β-lactamase hydrolysis activity | Pseudomonas aeruginosa | ceftolozane tazobactam | Reslit | Candidate |
| G1D | - | - | Pseudomonas aeruginosa | ceftolozane tazobactam | Reslit | Candidate |
| T79A | - | - | Pseudomonas aeruginosa | ceftolozane tazobactam | Reslit | Candidate |
| V179L | - | - | Pseudomonas aeruginosa | ceftolozane tazobactam | Reslit | Candidate |
| V329I | - | - | Pseudomonas aeruginosa | ceftolozane tazobactam | Reslit | Candidate |
| G364A | - | - | Pseudomonas aeruginosa | ceftolozane tazobactam | Reslit | Candidate |
| P180L | - | increased activity of the enzyme against the ceftazidime substrate | Pseudomonas aeruginosa | ceftazidime | Reslit | Candidate |
| G242R | - | increased activity of the enzyme against the ceftazidime substrate | Pseudomonas aeruginosa | ceftazidime | Reslit | Candidate |
| D154G | - | - | Pseudomonas aeruginosa | piperacillin tazobactam|ceftazidime | Reslit | Candidate |
| V239A | - | - | Pseudomonas aeruginosa | aztreonam | Reslit | Candidate |
| D272N | - | - | - | meropenem | Reslit | Candidate |
| L320P | - | - | - | meropenem | Reslit | Candidate |
| - | - | - | cephalosporins | Reslit | Candidate | |
| - | - | Escherichia coli | - | Reslit | Candidate | |
| - | - | Escherichia coli | cephalosporins|penicillin|aztreonam | Reslit | Candidate | |
| - | increased sensitivity | Pseudomonas aeruginosa | piperacillin tazobactam|ceftazidime | Reslit | Candidate | |
| - | - | Escherichia coli, Klebsiella pneumoniae | amoxicillin|amoxicillin clavulanic acid | Reslit | Candidate | |
| - | increasing resistance, ampC/blaEC promoter region | Escherichia coli | cephalosporins | ReslitReference Gene Catalog | Candidate | |
| - | - | Escherichia coli | - | Reslit | Candidate | |
| - | hyperproduction of AmpC beta-lactamase | Escherichia coli | beta lactams | Reslit | Candidate | |
| - | Enzymatic degradation, ampC/blaEC promoter region | Escherichia coli | ampicillin|ampicillin clavulanic acid|amoxicillin|amoxicillin clavulanic acid|cefixime|cefotaxime|cefoxitin|ceftazidime|piperacillincephalosporins | ResFinder DatabaseReference Gene Catalog | Candidate | |
| - | Enzymatic degradation, ampC/blaEC promoter region | Escherichia coli | ampicillin|ampicillin clavulanic acid|amoxicillin|amoxicillin clavulanic acid|cefixime|cefotaxime|cefoxitin|ceftazidime|piperacillincephalosporins | ResFinder DatabaseReference Gene Catalog | Candidate | |
| - | increased expression of the chromosomal ampC gene, hyperproduction of AmpC beta-lactamase, Enzymatic degradation, ampC/blaEC promoter region | Escherichia coli, E. fergusonii, Klebsiella pneumoniae | cefotaximecefotaxime|ceftazidimecefoxitin+3 more | ReslitResFinder DatabaseReference Gene Catalog | Candidate | |
| - | - | Pseudomonas aeruginosa | imipenem|ampicillin | Reslit | Candidate | |
| - | - | Escherichia coli | - | Reslit | Candidate | |
| - | - | Escherichia coli | ceftazidime|cefotaxime|cefepime|cefoxitin | Reslit | Candidate | |
| - | - | - | imipenem | Reslit | Candidate | |
| - | hyperproduction of AmpC beta-lactamase | Escherichia coli | cefoxitin|cefazolin|ampicillin|cefotaxime|ceftazidime|ceftriaxonebeta lactams | Reslit | Candidate | |
| - | - | Escherichia coli | - | Reslit | Candidate | |
| - | ampC/blaEC promoter region | Escherichia coli | cephalosporins | Reference Gene Catalog | Candidate | |
| - | hyperproduction of AmpC beta-lactamase | Escherichia coli, Klebsiella pneumoniae | ceftazidime|cefotaxime|cefepime|cefoxitincephalosporins|penicillin|aztreonamcefoxitin+1 more | Reslit | Candidate | |
| - | - | Escherichia coli | - | Reslit | Candidate | |
| - | - | Escherichia coli | ampicillin | Reslit | Candidate | |
| - | - | Escherichia coli | cefoxitin|cefazolin|ampicillin|cefotaxime|ceftazidime|ceftriaxonecephalosporins|penicillin|aztreonam | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | imipenem|ampicillin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | imipenem|ampicillin | Reslit | Candidate | |
| - | - | Escherichia coli | - | Reslit | Candidate | |
| - | - | E. coli | amoxicillin | Reslit | Candidate | |
| - | - | Escherichia coli | ceftazidime|cefotaxime|cefepime|cefoxitin | Reslit | Candidate | |
| - | ampC/blaEC promoter region | Escherichia coli | cephalosporins | Reference Gene Catalog | Candidate | |
| - | - | Escherichia coli | cephalosporins|penicillin|aztreonam | Reslit | Candidate | |
| - | Enzymatic degradation, ampC/blaEC promoter region | Escherichia coli, Klebsiella pneumoniae | amoxicillin|ampicillin|amoxicillin clavulanic acid|cephalosporinsceftazidime|cefotaxime|cefepime|cefoxitincefoxitin|cefixime|cefuroxime+3 more | ReslitResFinder DatabaseReference Gene Catalog | Candidate | |
| - | Enzymatic degradation, ampC/blaEC promoter region | Escherichia coli | ampicillin|ampicillin clavulanic acid|amoxicillin|amoxicillin clavulanic acid|cefixime|cefotaxime|cefoxitin|ceftazidime|piperacillincephalosporins | ResFinder DatabaseReference Gene Catalog | Candidate | |
| - | Enzymatic degradation, ampC/blaEC promoter region | Escherichia coli | ampicillin|ampicillin clavulanic acid|amoxicillin|amoxicillin clavulanic acid|cefixime|cefotaxime|cefoxitin|ceftazidime|piperacillincephalosporins | ResFinder DatabaseReference Gene Catalog | Candidate | |
| - | - | Escherichia coli | cefoxitin|cefotaxime|ceftazidime|ampicillin | Reslit | Candidate | |
| - | - | Escherichia coli | - | Reslit | Candidate | |
| - | - | Escherichia coli | cephalosporins|penicillin|aztreonam | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | ceftolozane tazobactam | Reslit | Candidate | |
| - | - | Escherichia coli, Klebsiella pneumoniae | cefoxitin | Reslit | Candidate | |
| - | - | Escherichia coli, Klebsiella pneumoniae | cefoxitin | Reslit | Candidate | |
| - | Enzymatic degradation | Escherichia coli | ampicillin|ampicillin clavulanic acid|amoxicillin|amoxicillin clavulanic acid|cefixime|cefotaxime|cefoxitin|ceftazidime|piperacillin | ResFinder Database | Candidate | |
| - | Enzymatic degradation | Escherichia coli | ampicillin|ampicillin clavulanic acid|amoxicillin|amoxicillin clavulanic acid|cefixime|cefotaxime|cefoxitin|ceftazidime|piperacillin | ResFinder Database | Candidate | |
| - | Enzymatic degredation | Escherichia coli | ampicillin|ampicillin clavulanic acid|amoxicillin|amoxicillin clavulanic acid|cefixime|cefotaxime|cefoxitin|ceftazidime|piperacillin | ResFinder Database | Candidate | |
| - | Enzymatic degredation | Escherichia coli | ampicillin|ampicillin clavulanic acid|amoxicillin|amoxicillin clavulanic acid|cefixime|cefotaxime|cefoxitin|ceftazidime|piperacillin | ResFinder Database | Candidate | |
| - | Enzymatic degredation | Escherichia coli | ampicillin|ampicillin clavulanic acid|amoxicillin|amoxicillin clavulanic acid|cefixime|cefotaxime|cefoxitin|ceftazidime|piperacillin | ResFinder Database | Candidate |
| Allele | Database | Papers | Drug Classes | Organisms | Countries | Years | Sequence Accession | Protein Accession |
|---|---|---|---|---|---|---|---|---|
| ampC | Reference Gene CatalogReslit | 200 | BETA-LACTAM, cephalosporins +43 | Edwardsiella tarda +75 | Taiwan, South Africa, Belgium|Spain|Italy|Germany, United States, Hong Kong, Australia, Shanghai|Shanghai, China, Europe, Hong Kong, China, Spain, France, Germany, Los Angeles County, California, Iran, South Korea, Canada, Egypt, United Kingdom|Ireland, Europe|Switzerland|Canada, United States|coastal wetlands, Denmark|United States, Mexico|United States|China|Europe|Asia, United Kingdom|Ireland|Sweden|Pakistan|Syria|USA|Belgium, Manitoba, Canada, Utah, UK, Malawi, China, southwestern Nigeria, Eastern Cape Province, South Africa, Global, USA|Canada, Kashmir valley, India, Arizona, USA, Oman, Ethiopia, Norway|China, Italy|Europe, United Kingdom|England|Australia, Northeastern Ohio, the United States|Northeastern Ohio, Switzerland, India|Ghana|Nepal|Laos, Upper Gulf of Thailand|Thailand|Ireland, South Florida, Brazil, Lebanon, Italy|Taiwan|Spain|China|Australia|United States|Egypt|Bolivia, Turkiye, Southwest Nigeria, Norway, Europe|Australia|Asia|Belgium|Germany|Switzerland, Atlanta, Southern Malaysia, Bulgaria, Burkina Faso, India, Madrid|Spain, Texas, Southeastern United States, Jos, Nigeria, Vietnam, Asia/South Pacific|Europe|Latin America|Middle East/Africa|North America, California, Mexico, Singapore, Sweden, Republic of Korea, Europe|Switzerland, Romania | 1999, 2000, 2001, 2003, 2004, 2005, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025 | EF467366.1 | ABO48510.1 |
| Abau_ampC | Card Database | 1 | - | Acinetobacter baumannii AB0057 | - | - | CP001182.1 | ACJ42146.1 |
| Ecol_ampC_BLA | Card Database | 1 | - | Escherichia coli str. K-12 substr. MG1655 | - | - | U00096.3 | AAC77110.1 |
| Rsph_ampC_BLA | Card Database | 1 | - | Cereibacter sphaeroides 2.4.1 | - | - | CP000144.2 | ABA81355.1 |
| amp | Reslit | 6 | ampicillin | Salmonella enterica +8 | France, Europe|Asia|Africa|North America|South America|Australia|Thailand|South Korea|Vietnam|China|Poland|Iran|Egypt|India|Finland|Cambodia|Nigeria|Malaysia|United Kingdom|Germany|Sweden|New Zealand|Northern Ireland|Taiwan|Denmark|France|USA, Ede, Nigeria|Ede, Osun State, Nigeria, Peruvian Amazon | 2017, 2019, 2021, 2024, 2025 | HM134859.1 | - |
| amp C /bla DHA | Reslit | 1 | cephalosporins | Klebsiella pneumoniae | China | 2024 | - | - |
| amp C | Reslit | 1 | penicillin, cephalosporins | Clostridium perfringens | Egypt | 2025 | - | - |
| AMP | Reslit | 1 | ampicillin | Enterobacter hormaechei +5 | Europe|unknown | 2025 | PV843919|PV843920|PV843921|PV843922|PV843923|PV843924|PV843925|PV843926|PV843927|PV843928|PV843929|PV843930|PV843931|PV843932|PV843933|PV843934|PV843833|PV843834|PV843835|PV843836|PV843837|PV843838|PV843839|PV843840|PV843841|PV843842|PV843843|PV843844|PV843845|PV843846|PV843847|PV843848|PV843849|PV843850|PV843851|PV843852|PV843853|PV843854|PV843855|PV843856|PV843857|PV843858|PV843859|PV843860|PV843861|PV843862|PV843863|PV843864|PV843865|PV843866|PV843867|PV843868|PV843869|PV843870|PV843871|PV843872|PV843873|PV843874|PV843875|PV843876|PV843877|PV843878|PV843879|PV843880|PV843881|PV843882|PV843883|PV843884|PV843885|PV843886|PV843887|PV843888|PV843889|PV843890|PV843891|PV843892|PV843893|PV843894|PV843895|PV843896|PV843897|PV843898|PV843899|PV843900|PV843901|PV843902|PV843903|PV843904|PV843905|PV843906|PV843907|PV843908|PV843909|PV843910|PV843911|PV843912|PV843913 | - |
Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates.
The study identified and characterized the ampC and ampR genes from Morganella morganii clinical isolates, demonstrating that ampC encodes a beta-lactamase responsible for cephalosporin resistance, and ampR regulates its expression.
Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin.
Clavulanate induces expression of the AmpC cephalosporinase in Pseudomonas aeruginosa, leading to reduced susceptibility to ticarcillin. This induction occurs at clinically relevant concentrations and antagonizes the antibacterial activity of ticarcillin.
Biological cost of AmpC production for Salmonella enterica serotype Typhimurium.
The study demonstrates that the production of AmpC β-lactamase in Salmonella enterica serotype Typhimurium leads to a biological cost, affecting colony morphology, cell size, growth rate, invasion rates, and intracellular replication. The presence of the regulatory gene ampR reverses these effects.
Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
The study identifies MexAB-OprM efflux system and AmpC beta-lactamase as key contributors to intrinsic penem resistance in Pseudomonas aeruginosa, along with the outer membrane barrier.
Mutation in Serratia marcescens AmpC beta-lactamase Producing High-Level Resistance to Ceftazidime and Cefpirome.
The study identifies a mutation in the Serratia marcescens AmpC beta-lactamase gene (Thr64→Ile) that leads to high-level resistance to ceftazidime and cefpirome. This mutation enhances the catalytic efficiency of the enzyme towards these antibiotics.
High-level expression of ampC beta-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment.
The study identifies mutations in the ampC promoter region leading to high-level expression of the AmpC beta-lactamase in E. coli clinical isolates, causing resistance to extended-spectrum cephalosporins.
Genetic Environment and Transcription of ampC in an Acinetobacter baumannii Clinical Isolate.
The ampC gene from Acinetobacter baumannii strain RAN was cloned and shown to confer resistance to cephalothin, cefuroxime, and cefoxitin when expressed in E. coli.
Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production.
Exposure of Pseudomonas aeruginosa biofilms to imipenem led to significant changes in gene expression, including a 67- to 150-fold induction of the ampC gene, which encodes the chromosomal beta-lactamase. Additionally, alginate biosynthesis genes were induced, resulting in increased alginate production.
Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa.
Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.
The study identified AmpC hyperproduction as the primary mechanism of resistance to ceftazidime (CAZ) in Pseudomonas aeruginosa, both in vitro and in vivo. This resistance mechanism was observed in both wild-type and hypermutable strains, with increased beta-lactamase activity contributing to resistance against β-lactam antibiotics.
Development of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro.
The study identified mutations in the oprD gene leading to reduced susceptibility to meropenem and overproduction of AmpC beta-lactamase contributing to resistance to ceftazidime in Pseudomonas aeruginosa strains.
Epigenetic inheritance based evolution of antibiotic resistance in bacteria.
The study identifies AmpC, GadA, and GadB as genes involved in epigenetic-based antibiotic resistance in E. coli, demonstrating that gene expression changes can lead to resistance without DNA mutations. Additionally, the DNA methyltransferase dam was found to influence resistance to nalidixic acid.
Quantitative PCR monitoring of antibiotic resistance genes and bacterial pathogens in three European artificial groundwater recharge systems.
The study identified the presence of antibiotic resistance genes including tetO, ermB, mecA, blaSHV-5, ampC, and vanA in reclaimed water from three European artificial groundwater recharge systems. These genes were detected using real-time qPCR, indicating their potential impact on the environment.
Genetic architecture of intrinsic antibiotic susceptibility.
The study identifies multiple genes and mutations that contribute to antibiotic tolerance in E. coli, revealing a large mutational target size for increasing drug resistance. Key findings include the role of genes involved in electron transport, flagella synthesis, and efflux pumps in modulating susceptibility to various antibiotics.
Characterization of beta-lactamase genes and their regulatory mechanisms in Gram-negative bacteria
The study characterizes the chromosomal beta-lactamase gene ampC and its regulatory genes ampR, ampD, ampE, and ampG in various Gram-negative bacteria, highlighting their roles in cephalosporin resistance.
Differential selection of single-step AmpC or efflux mutants of Pseudomonas aeruginosa by using cefepime, ceftazidime, or ceftobiprole.
The study identified that ceftazidime-selected mutants overexpressed AmpC beta-lactamase, while ceftobiprole-selected mutants primarily exhibited upregulation of the mexXY efflux system. Cefepime-selected mutants showed variable resistance mechanisms including AmpC overexpression or mexXY upregulation.
Antimicrobial Susceptibility and Multiplex PCR Screening of AmpC Genes From Isolates of Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens.
The study identified ampC genes of DHA, EBC, and CIT types in Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens isolates, along with TEM, CTX-M-3-like, and SHV genes, demonstrating their roles in conferring resistance to various beta-lactam antibiotics.
Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity.
The study identified several AMR genes in Acinetobacter baumannii, including blaOXA-69, which confers resistance to carbapenems, and AdeT, an RND-type efflux pump involved in aminoglycoside resistance. AmpC cephalosporinase was also found to contribute to resistance against cephalosporins.
Virulence determinants, drug resistance and mobile genetic elements of Laribacter hongkongensis: a genome-wide analysis.
The study identifies several β-lactam resistance genes, including ampC, lacA, pbp2, pbp3, pbp4a, pbp6a, and pbp7, as well as multidrug efflux pumps such as acrAB-tolC, acrAD-tolC, mdtABC-tolC, emrAB-tolC, mexAB-oprM, and others. Additionally, genes like bacA, ksgA, crcB, and rarD are implicated in resistance to bacitracin, kasugamycin, streptomycin, camphor, and chloramphenicol, respectively.
Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-throughput genome sequencing.
The study identified multiple AMR genes in a multidrug-resistant E. coli strain, including blaNDM-1, blaTEM-1, blaCTX-M-15, and others, along with chromosomal mutations in gyrA, parC, ompC, and ompF contributing to resistance.
Genomic analysis and temperature-dependent transcriptome profiles of the rhizosphere originating strain Pseudomonas aeruginosa M18.
The study identifies several AMR genes in Pseudomonas aeruginosa M18, including beta-lactamase ampC and efflux pumps mexAB-oprM, mexCD-oprJ, and mexEF-oprN, which confer resistance to various antibiotics. The strain M18 is more susceptible to certain antimicrobials compared to LESB58.
A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.
The study identifies the hyperproduction of the chromosomal cephalosporinase AmpC and the inactivation of the OprD porin as the primary mechanisms of multidrug resistance in a Pseudomonas aeruginosa outbreak.
Plasmid metagenome reveals high levels of antibiotic resistance genes and mobile genetic elements in activated sludge.
The study identified several antibiotic resistance genes, including tetB(P), aadA5, ampC, macB, IS Pps1, and IS Sm2, in the plasmid metagenome of activated sludge, highlighting the presence of diverse resistance mechanisms in environmental microbial communities.
The regulatory repertoire of Pseudomonas aeruginosa AmpC ß-lactamase regulator AmpR includes virulence genes.
AmpR is a global regulator in P. aeruginosa that influences the expression of over 500 genes, including those involved in β-lactam resistance, virulence, and biofilm formation.
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.
The study identifies genetic markers of extensive drug-resistant Pseudomonas aeruginosa high-risk clones, including ampC hyperproduction, oprD inactivation, aadB gene production, and mexZ mutations, along with specific mutations in ampR, gyrA, and parC that contribute to resistance.
Whole-genome sequencing and identification of Morganella morganii KT pathogenicity-related genes.
The study identified several AMR genes in Morganella morganii KT, including ampC, metallo-beta-lactamase genes (MM2254, MM2308, MM2606), tetAJ, catA2, bcr, and ksgA, which confer resistance to various antibiotics such as beta-lactams, carbapenems, tetracycline, chloramphenicol, bicyclomycin, and kasugamycin.
Involvement of Fe uptake systems and AmpC beta-lactamase in susceptibility to the siderophore monosulfactam BAL30072 in Pseudomonas aeruginosa.
The study identifies ampC beta-lactamase overexpression as a mechanism of resistance to BAL30072 in Pseudomonas aeruginosa, along with the involvement of the FecIRA Fe-dicitrate transporter and PiuA iron receptor in susceptibility.
Compensation of the Metabolic Costs of Antibiotic Resistance by Physiological Adaptation in Escherichia coli.
The study identifies ampC as a gene that confers amoxicillin resistance through a promoter mutation leading to increased beta-lactamase activity in Escherichia coli.
Identification of novel genes responsible for overexpression of ampC in Pseudomonas aeruginosa PAO1.
The study identifies mpl and nuoN as novel genes responsible for the overexpression of ampC in Pseudomonas aeruginosa PAO1, leading to increased resistance to β-lactam antibiotics.
LTQ-XL mass spectrometry proteome analysis expands the Pseudomonas aeruginosa AmpR regulon to include cyclic di-GMP phosphodiesterases and phosphoproteins, and identifies novel open reading frames.
The study identified ampC as a gene regulated by AmpR, which encodes a beta-lactamase that confers resistance to cephalosporins in Pseudomonas aeruginosa.
Role of Pseudomonas aeruginosa AmpR on β-lactam and non-β-lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibiotics.
The study identifies AmpR and AmpC as key regulators in β-lactam and non-β-lactam transient cross-resistance in Pseudomonas aeruginosa upon pre-exposure to subinhibitory concentrations of antibiotics.
Emergence of Escherichia coli producing extended-spectrum AmpC beta-lactamases (ESAC) in animals.
The study reports the emergence of Escherichia coli producing extended-spectrum AmpC beta-lactamases (ESAC) in animals, highlighting the identification of specific mutations in the ampC gene that confer resistance to cephalosporins.
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC.
The study identifies mutations in the ampC gene of Pseudomonas aeruginosa that lead to overexpression and structural modifications of AmpC, contributing to resistance against ceftolozane-tazobactam and ceftazidime.
Interaction between mutations and regulation of gene expression during development of de novo antibiotic resistance.
The study identifies mutations in the ampC promoter region leading to amoxicillin resistance and mutations in gyrA and parC contributing to enrofloxacin resistance in E. coli.
A multiple antibiotic-resistant enterobacter cloacae strain isolated from a bioethanol fermentation facility.
The study identifies the presence of the ampC gene encoding a beta-lactamase and the ermG gene encoding a ribosomal methyltransferase in the multiple antibiotic-resistant Enterobacter cloacae strain F3S3, which confers resistance to penicillin and erythromycin respectively.
Comparative genomic analysis of Klebsiella pneumonia (LCT-KP214) and a mutant strain (LCT-KP289) obtained after spaceflight.
The study identified the sul1 gene duplication as a mechanism for sulfamethoxazole resistance in the spaceflight mutant strain LCT-KP289. Additionally, the ampC, emrE, and ant genes were found to contribute to drug resistance in both strains.
Mutation-driven β-lactam resistance mechanisms among contemporary ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates from U.S. hospitals.
The study identified ampC derepression and oprD loss as the primary mutation-driven resistance mechanisms in ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates from U.S. hospitals.
Whole genome and transcriptome analyses of environmental antibiotic sensitive and multi-resistant Pseudomonas aeruginosa isolates exposed to waste water and tap water.
The study identifies multiple AMR genes and mutations in the multi-resistant P. aeruginosa isolate PA49, including aac(6')-Ib, aadB, blaVIM-2, ampC, and mutations in gyrA, parC, and oprD, which confer resistance to various antibiotics.
DHA-1 plasmid-mediated AmpC beta-lactamase expression and regulation of Klebsiella pnuemoniae isolates.
The study identified mutations in the AmpC gene of DHA-1 plasmid-mediated Klebsiella pneumoniae isolates, which contribute to β-lactam resistance.
Label-free SRM-based relative quantification of antibiotic resistance mechanisms in Pseudomonas aeruginosa clinical isolates.
The study compares label-free SRM-based mass spectrometry with RT-qPCR for quantifying antibiotic resistance mechanisms in Pseudomonas aeruginosa, focusing on efflux pumps, AmpC beta-lactamase, and OprD porin. SRM showed superior accuracy in classifying efflux pump overexpression and predicting resistance.
Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4: epidemiology, resistance genetic determinants and potential virulence factors.
The study characterizes the resistance genetic determinants of the hypervirulent Acinetobacter baumannii strain LAC-4, identifying multiple beta-lactamases, aminoglycoside modifying enzymes, and RND-type efflux pumps contributing to its multidrug resistance.
Phenotypic and Molecular Characterization of Plasmid Mediated AmpC among Clinical Isolates of Klebsiella pneumoniae Isolated from Different Hospitals in Tehran.
The study detected plasmid-mediated AmpC beta-lactamase-producing Klebsiella pneumoniae isolates in Tehran hospitals, highlighting the low prevalence of AmpC producers and the limitations of phenotypic methods for detection.
Cell Wall Recycling-Linked Coregulation of AmpC and PenB beta-lactamases through ampD Mutations in Burkholderia cenocepacia.
Mutations in ampD in Burkholderia cenocepacia lead to the coregulation of AmpC and PenB beta-lactamases, conferring resistance to ceftazidime, cefotaxime, and meropenem.
Comparative Phosphoproteomics Reveals the Role of AmpC beta-lactamase Phosphorylation in the Clinical Imipenem-resistant Strain Acinetobacter baumannii SK17.
The study identifies that phosphorylation of AmpC beta-lactamase at Ser-90 regulates its activity and affects imipenem resistance in Acinetobacter baumannii SK17.
Comparative Phosphoproteomics Reveals the Role of AmpC β-lactamase Phosphorylation in the Clinical Imipenem-resistant Strain Acinetobacter baumannii SK17.
The study identifies that phosphorylation of AmpC β-lactamase at Ser-90 regulates its activity and affects imipenem resistance in Acinetobacter baumannii SK17.
Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.
PAHM4 exhibits resistance to multiple antibiotics, including β-lactams, aminoglycosides, and fluoroquinolones, due to mutations in genes such as ampC, creD, mexB, gyrA, parC, and parE, as well as a mutS mutation leading to hypermutation.
Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.
Transcriptome Profiling of Antimicrobial Resistance in Pseudomonas aeruginosa.
The study identifies multiple AMR genes and mutations in Pseudomonas aeruginosa, including aadA1, aadA6, aacA4, aacA7, aacA5, blaOXA-2, blaOXA-4, blaVIM-1, blaVIM-2, blaGIM-2, blaIMP-1, blaIMP-7, blaPER-1, blaCTX-M-3, ampC, gyrA (T83I), and parC (S87L/W), which are associated with resistance to various antibiotics such as tobramycin, ceftazidime, meropenem, and ciprofloxacin.
Detection of Antibiotic Resistance Genes in Source and Drinking Water Samples from a First Nations Community in Canada.
The study identified several antibiotic resistance genes, including ampC, tet(A), and mecA, in water samples from a First Nations community in Canada, highlighting concerns about water quality and potential health risks.
Antibiotic resistance in Burkholderia species.
The paper discusses the mechanisms of antibiotic resistance in Burkholderia species, focusing on β-lactam resistance mediated by penA, penB, and ampC beta-lactamases, as well as efflux pumps like AmrAB-OprA, BpeAB-OprB, and BpeEF-OprC. It also highlights mutations in penA and gyrA that contribute to resistance against β-lactam and fluoroquinolone antibiotics.
Antimicrobial and antioxidant activities of Saccharomyces cerevisiae IFST062013, a potential probiotic.
The study identifies Saccharomyces cerevisiae IFST 062013 as a potential probiotic with resistance to tetracycline, ampicillin, gentamicin, penicillin, polymyxin B, and nalidixic acid.
Carbapenem Susceptibility and Multidrug-Resistance in Pseudomonas aeruginosa Isolates in Egypt.
The study identified Metallo-β-Lactamase (MBL) and Amp C β-lactamase production in Pseudomonas aeruginosa isolates from Egypt, highlighting the prevalence of carbapenem resistance and multidrug resistance.
Evolution and Epidemiology of Multidrug-Resistant Klebsiella pneumoniae in the United Kingdom and Ireland.
The study identifies several AMR genes and mutations associated with multidrug-resistant Klebsiella pneumoniae in the UK and Ireland, including beta-lactamases, aminoglycoside-modifying enzymes, tetracycline efflux pumps, and mutations in gyrB contributing to fluoroquinolone resistance.
Indole-Induced Activities of beta-lactamase and Efflux Pump Confer Ampicillin Resistance in Pseudomonas putida KT2440.
Indole induces ampicillin resistance in Pseudomonas putida KT2440 and P. aeruginosa PAO1 through the upregulation of ampC, encoding a beta-lactamase, and RND-type efflux pumps.
Prevalence, virulence potential, and pulsed-field gel electrophoresis profiling of Shiga toxin-producing Escherichia coli strains from cattle.
The study identified various antimicrobial resistance genes in STEC isolates from cattle, including ampC, blaTEM, tetE, tetB, and tetC, which confer resistance to beta-lactams and tetracyclines. These findings highlight the importance of monitoring antimicrobial resistance in STEC strains.
TCDD influences reservoir of antibiotic resistance genes in murine gut microbiome.
TCDD exposure leads to an increase in antibiotic resistance genes (ARGs) and mobile genetic elements (MGEs) in the murine gut microbiome, particularly in Enterobacteriaceae, with specific genes like blaCMY2, ampC, and various MDR genes being significantly enriched.
Acinetobacter baumannii quorum-sensing signalling molecule induces the expression of drug-resistance genes.
The study identifies that the quorum-sensing signaling molecule N-3-OH-C12-HSL induces the expression of drug-resistance genes OXA-51, AmpC, AdeA, and AdeB in Acinetobacter baumannii, enhancing resistance to meropenem.
Biofilm Formation Potential of Heat-Resistant Escherichia coli Dairy Isolates and the Complete Genome of Multidrug-Resistant, Heat-Resistant Strain FAM21845.
The study identified multiple antimicrobial resistance genes in the multidrug-resistant, heat-resistant E. coli strain FAM21845, including beta-lactamase blaTEM-1, aminoglycoside resistance genes strA, strB, aadA1, aph(3')-Ic, aph(4)-Ia, aac(3)-IVa, sulfonamide resistance gene sul1, trimethoprim resistance gene dfrA1, tetracycline resistance gene tet(B), disinfectant resistance gene qacEΔ1, and biofilm-related genes mrkABCDF. Additionally, the strain carried genes for resistance to arsenic, silver, and copper.
Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
The study identified various AMR genes and mutations in extensively drug-resistant Pseudomonas aeruginosa isolates from Spain, including beta-lactamases, aminoglycoside-modifying enzymes, and mutations in genes such as ampC, oprD, gyrA, parC, mexZ, and glpT, which contribute to resistance against multiple antibiotics.
Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.
The study identifies several beta-lactamases and efflux pumps contributing to antibiotic resistance in Burkholderia cenocepacia, highlighting the complexity of its resistance mechanisms.
Characterization of Four Multidrug Resistance Plasmids Captured from the Sediments of an Urban Coastal Wetland.
Four multidrug resistance plasmids were captured from the sediments of an urban coastal wetland. These plasmids carried various resistance genes, including beta-lactamases, tetracycline resistance genes, sulfonamide resistance genes, and others, conferring resistance to multiple antibiotics.
Coupling next-generation sequencing to dominant positive screens for finding antibiotic cellular targets and resistance mechanisms in Escherichia coli.
The study identifies several genes whose overexpression leads to increased resistance to various antibiotics in E. coli, including ftsI, ampC, nlpE, marC, rob, soxS, sdiA, folA, and yebV.
Detection of antimicrobial resistance-associated proteins by titanium dioxide-facilitated intact bacteria mass spectrometry.
The study demonstrates the successful detection of antimicrobial resistance-associated proteins using TiO2-facilitated MALDI-TOF MS without sample pre-treatment. Specific resistance proteins such as blaTEM-1, aacC1, cat, and ampC were identified in various bacterial strains.
Pseudomonas aeruginosa transcriptome during human infection.
The study identifies several P. aeruginosa genes that are induced during human infections and are associated with antibiotic resistance mechanisms, including efflux pumps, beta-lactamases, and other resistance determinants.
Antibacterial Spectrum of a Tetrazole-Based Reversible Inhibitor of Serine beta-lactamases.
The study characterizes the antibacterial spectrum of a tetrazole-based reversible inhibitor of serine beta-lactamases, showing significant activity against various CTX-M subtypes and other serine beta-lactamases, including CTX-M-9, CTX-M-14, CTX-M-15, CTX-M-27, SHV-2, KPC-2, AmpC, OXA-48, and TEM-1.
The Genomic Basis of Intrinsic and Acquired Antibiotic Resistance in the Genus Serratia.
The study identified 123 distinct antibiotic resistance genes (ARGs) in the genus Serratia, including intrinsic and acquired resistance genes, as well as efflux pump-related genes. Key findings include the detection of various beta-lactamases, aminoglycoside resistance genes, quinolone resistance genes, and efflux pumps. Notably, the study highlights the presence of plasmid-borne ARGs in nosocomial strains and the role of efflux pumps in multidrug resistance.
Molecular Typing and Carbapenem Resistance Mechanisms of Pseudomonas aeruginosa Isolated From a Chinese Burn Center From 2011 to 2016.
A pan-genome-based machine learning approach for predicting antimicrobial resistance activities of the Escherichia coli strains.
The study identifies and characterizes several AMR genes in E. coli, including beta-lactamases (blaTEM-1, blaOXA-1, blaCMY-2, ampC), aminoglycoside modifying enzymes (aac(3')-Ia, aac(3')-VI), dihydrofolate reductases (dfrA1, dfrA5, dfrA12, dfrA15), quinolone resistance proteins (qnrB2, qnrB6, qnrS2), and others. These genes were validated through computational and wet lab methods, showing their roles in conferring resistance to various antibiotics.
Nonoptimal Gene Expression Creates Latent Potential for Antibiotic Resistance.
The study identifies numerous genes whose expression changes can confer resistance to various antibiotics, highlighting the role of nonoptimal gene expression in antibiotic resistance development.
Applying Rapid Whole-Genome Sequencing To Predict Phenotypic Antimicrobial Susceptibility Testing Results among Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates.
The study identified various AMR genes and mutations in carbapenem-resistant Klebsiella pneumoniae isolates, including bla KPC-2, bla KPC-3, bla NDM-1, bla OXA-48, ampC, qnrB, qnrS, aac(6')-Ib-cr, armA, rmtB, tet(A), tet(B), tet(D), tet(G), sul1, sul2, sul3, dfrA1, dfrA12, dfrA14, dfrA25, dfrA26, dfrA30, oqxA, oqxB, and mgrB, as well as mutations in ompK35, ompK36, gyrA, parC, phoP, phoQ, pmrA, and pmrB, which contribute to resistance against multiple antibiotics.
Effect of β-lactam antibiotic resistance gene expression on the radio-resistance profile of E. coli O157:H7.
The study shows that the expression of ampC and ampG genes in E. coli O157:H7 contributes to radioresistance, particularly when the bacteria are adapted to carbenicillin. Mutants lacking these genes showed increased sensitivity to irradiation.
Prediction of antibiotic resistance in Escherichia coli from large-scale pan-genome data.
The study predicts antibiotic resistance in E. coli using machine learning models trained on pan-genome data, identifying key resistance genes such as bla-CTX-M, ampC, dfrA, qep, and oxa.
Genome rearrangements in Escherichia coli during de novo acquisition of resistance to a single antibiotic or two antibiotics successively.
The study identifies ampC gene amplification as a mechanism for de novo amoxicillin resistance in E. coli, along with various deletions and insertions mediated by transposable elements.
Genomic and Virulence Characterization of Intrauterine Pathogenic Escherichia coli With Multi-Drug Resistance Isolated From Cow Uteri With Metritis.
The study identified multiple beta-lactamase genes, including bla CTX-M, bla CMY, bla TEM, and ampC, in intrauterine pathogenic E. coli (IUPEC) isolates from cows with metritis, which conferred resistance to cephalosporins like cefotaxime and ceftiofur.
In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways.
The study identifies mutations in the ampC gene, specifically V213A and Δ7, as contributing to ceftolozane/tazobactam resistance in Pseudomonas aeruginosa. The V213A mutation increases beta-lactamase activity, while the Δ7 mutation does not.
Detection of fecal bacteria and antibiotic resistance genes in drinking water collected from three First Nations communities in Manitoba, Canada.
The study identified the presence of antibiotic resistance genes (ARGs) including ampC, mecA, and sul1 in drinking water samples from First Nations communities in Manitoba, Canada, highlighting potential risks to water safety.
Insights into the Periplasmic Proteins of Acinetobacter baumannii AB5075 and the Impact of Imipenem Exposure: A Proteomic Approach.
The study identifies several periplasmic proteins involved in antibiotic resistance in Acinetobacter baumannii AB5075, including the beta-lactamases AmpC, OXA-23, and GES-11, as well as the RND-type efflux pump AdeT. Additionally, a novel metal-dependent hydrolase, ABUW_0920, was identified, suggesting potential roles in beta-lactam resistance.
Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection.
The study identified multiple AMR genes and mutations in E. coli ST131 isolates from a patient with recurrent UTIs, including plasmid-borne resistance genes and chromosomal mutations contributing to fluoroquinolone resistance.
Animal Breed Composition Is Associated With the Hindgut Microbiota Structure and β-Lactam Resistance in the Multibreed Angus-Brahman Herd.
The study found that β-lactam resistance genes, including ampC and arcA, were more abundant in postweaning heifers with a higher Brahman proportion.
Contrasting patterns of longitudinal population dynamics and antimicrobial resistance mechanisms in two priority bacterial pathogens over 7 years in a single center.
The study identified bla CTX-M-15 as a key determinant of cephalosporin resistance in Klebsiella pneumoniae and Enterobacter cloacae, while Enterobacter cloacae relied on chromosomal ampC for intrinsic resistance.
Impact of cleaning and disinfection procedures on microbial ecology and Salmonella antimicrobial resistance in a pig slaughterhouse.
The study identified resistance to ampicillin, sulfamethoxazole, and tetracycline in Salmonella isolates from a pig slaughterhouse, with no significant changes in resistance patterns after cleaning and disinfection procedures.
Effect of Environment on the Evolutionary Trajectories and Growth Characteristics of Antibiotic-Resistant Escherichia coli Mutants.
The study identifies a promoter mutation in the ampC gene leading to increased AmpC beta-lactamase production and resistance to amoxicillin-clavulanic acid in E. coli.
Identification of Drug Resistance Determinants in a Clinical Isolate of Pseudomonas aeruginosa by High-Density Transposon Mutagenesis.
The study identifies several nonessential genes involved in β-lactam resistance in Pseudomonas aeruginosa, including ampC, mltG, mepM1, amgK, and ygfB, which contribute to the induction of ampC expression and resistance against meropenem and cefepime.
Phylogenetic Diversity, Antimicrobial Susceptibility and Virulence Characteristics of Escherichia coli Isolates from Pigeon Meat.
The study identified several AMR genes in E. coli isolates from pigeon meat, including ampC, aadA, cmlA, sul1, sul2, and sul3, which confer resistance to beta-lactams, aminoglycosides, chloramphenicol, and sulfonamides.
Overexpression of AmpC Promotes Bacteriophage Lysis of Ampicillin-Resistant Escherichia coli.
Overexpression of AmpC, a beta-lactamase, increases the susceptibility of ampicillin-resistant E. coli to phage lysis by promoting the expression of the phage receptor protein OmpA.
A survey of extended-spectrum beta-lactamase-producing Enterobacteriaceae in urban wetlands in southwestern Nigeria as a step towards generating prevalence maps of antimicrobial resistance.
The study identified the presence of extended-spectrum beta-lactamase genes bla CTX-M-15, bla TEM-1B, bla OXA-1, and ampC in Enterobacteriaceae isolates from urban wetlands in Nigeria, highlighting the significant contamination of these environments with clinically relevant antimicrobial resistance genes.
Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to Cefepime.
The study identifies a 2-amino acid deletion in the R2 loop of AmpC beta-lactamase as the mechanism of ceftazidime-avibactam, cefepime, and cefiderocol resistance in Enterobacter hormaechei.
Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol in Enterobacter cloacae Due to AmpC R2 Loop Deletion.
A two amino acid deletion in the R2 loop of AmpC β-lactamases in Enterobacter cloacae leads to reduced susceptibility to ceftazidime-avibactam and cefiderocol due to structural changes enhancing hydrolysis of these antibiotics.
Prevalence and distribution of antimicrobial resistance determinants of Escherichia coli isolates obtained from meat in South Africa.
The study identified several AMR genes in E. coli isolates from meat in South Africa, including aadA, strA, aph(3)-Ia, aph(3)-IIa, aac(3)-IIa, blaTEM, blaZ, ampC, cat1, cat2, cmlA1, sul1, sul2, tetA, tetB, tetC, tetD, and tetM, which confer resistance to various antibiotics such as streptomycin, kanamycin, neomycin, gentamicin, amoxicillin, ampicillin, chloramphenicol, cotrimoxazole, and tetracycline.
Mechanisms for Rapid Evolution of Carbapenem Resistance in a Clinical Isolate of Pseudomonas aeruginosa.
The study identifies that the carbapenem resistance in IRP41 is primarily due to the ampC hyper-expression and an inactive OprD caused by a G831A substitution. Additionally, a frameshift mutation in ldcA leads to increased ampC expression, contributing to resistance.
Molecular basis of the beta-lactamase protein using comparative modelling, drug screening and molecular dynamics studies to understand the resistance of β-lactam antibiotics.
The study identifies ampC beta-lactamase from Morganella morganii as a key player in beta-lactam resistance and predicts OncoglabrinolC as a potential inhibitor through computational and experimental methods.
Adding Insult to Injury: Mechanistic Basis for How AmpC Mutations Allow Pseudomonas aeruginosa To Accelerate Cephalosporin Hydrolysis and Evade Avibactam.
Mutations in the ampC gene of Pseudomonas aeruginosa enhance resistance to ceftolozane and ceftazidime by increasing catalytic efficiency and reducing avibactam inhibition.
Occurrence, Virulence and Antimicrobial Resistance-Associated Markers in Campylobacter Species Isolated from Retail Fresh Milk and Water Samples in Two District Municipalities in the Eastern Cape Province, South Africa.
The study identified several antimicrobial resistance genes in Campylobacter species isolated from retail fresh milk and water samples, including catII, tetA, tetB, tetM, ermB, gyrA, ampC, and aac(3)-IIa-(aacC2). These genes were associated with resistance to chloramphenicol, tetracycline, erythromycin, gentamicin, and ampicillin.
Mechanisms Protecting Acinetobacter baumannii against Multiple Stresses Triggered by the Host Immune Response, Antibiotics and Outside-Host Environment.
This review discusses the mechanisms that protect Acinetobacter baumannii against multiple stresses, including those from the host immune response, antibiotics, and the outside environment. It highlights the role of surface glycoconjugates, outer membrane components, and various virulence factors in evading immune defenses and surviving adverse conditions.
Antibiotic resistance and extended-spectrum β-lactamase in Escherichia coli isolates from imported 1-day-old chicks, ducklings, and turkey poults.
The study identified various extended-spectrum beta-lactamase (ESBL) and ampC beta-lactamase genes, including bla TEM, bla SHV, bla CTX-M, bla OXA-1, and ampC, in Escherichia coli isolates from imported 1-day-old poultry. These genes conferred resistance to multiple beta-lactam antibiotics.
Impact of RBX2660 on the microbiome and resistome in patients with recurrent Clostridium difficile infection
RBX2660 introduced antibiotic-resistant organisms (AROs) with various resistance genes, including AmpC, TEM-1, CARB, and CTX-M-14, which conferred resistance to multiple antibiotics.
Bacterial isolates harboring antibiotics and heavy-metal resistance genes co-existing with mobile genetic elements in natural aquatic water bodies.
The study identified blaTEM, AmpC, qnrS, merB, merP, merT, silE, silP, silS, arsC, IntI, SulI, ISecp1, TN3, and TN21 as significant AMR genes in bacterial isolates from Dal and Wular Lakes in Kashmir, India. These genes were found to confer resistance to various antibiotics and heavy metals, highlighting the co-existence of antibiotic and metal resistance determinants in aquatic environments.
Bacterial Genome Wide Association Studies (bGWAS) and Transcriptomics Identifies Cryptic Antimicrobial Resistance Mechanisms in Acinetobacter baumannii.
The study identified several AMR genes and mutations in Acinetobacter baumannii, including beta-lactamases like blaOXA-23, blaOXA-64, and blaOXA-235, as well as aminoglycoside resistance genes like aadA1 and AAC(3)-Ia. It also found a gyrA S82L mutation associated with quinolone resistance.
Clinical and molecular characteristics of carbapenem non-susceptible Escherichia coli: A nationwide survey from Oman.
The study identified various carbapenemase genes, including blaNDM-5, blaNDM-1, blaNDM-4, blaNDM-7, blaOXA-181, and blaOXA-48, along with extended-spectrum beta-lactamase CTX-M-15, ampC beta-lactamase CMY-42, and penicillinases TEM-1B and OXA-1 in carbapenem-non-susceptible Escherichia coli isolates from Oman.
Andrographis paniculata extract inhibit growth, biofilm formation in multidrug resistant strains of Klebsiella pneumoniae.
The study identified the presence of the AmpC beta-lactamase gene in a multidrug-resistant strain of Klebsiella pneumoniae and demonstrated that the crude ethyl extract of Andrographis paniculata could suppress the expression of this gene, thereby reducing resistance to certain beta-lactam antibiotics.
Extended-spectrum Beta-lactamase and AmpC beta-lactamases producing gram negative bacilli isolated from clinical specimens at International Clinical Laboratories, Addis Ababa, Ethiopia.
The study identified extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase producing gram negative bacilli, primarily Escherichia coli and Klebsiella pneumoniae, with high rates of multidrug resistance. Key ESBLs identified include blaCTX-M, blaSHV, and blaTEM, while ampC was found in E. coli, K. pneumoniae, and Citrobacter spp.
Mechanisms of Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study.
The study identifies multiple mechanisms of resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa, including the production of extended-spectrum beta-lactamases (ESBLs) and carbapenemases, overproduction of the intrinsic cephalosporinase PDC, and mutations in regulatory and peptidoglycan recycling genes.
Elevating NagZ Improves Resistance to β-Lactam Antibiotics via Promoting AmpC beta-lactamase in Enterobacter cloacae.
NagZ enhances resistance to β-lactam antibiotics in Enterobacter cloacae by promoting the expression of chromosomal AmpC beta-lactamase.
Antibiotic Resistance and Phylogeny of Pseudomonas spp. Isolated over Three Decades from Chicken Meat in the Norwegian Food Chain.
The study identified several AMR genes and mutations in Pseudomonas spp. isolated from chicken meat in Norway, including beta-lactamases, efflux pumps, and genes involved in resistance to aminoglycosides, fluoroquinolones, and colistin.
Advanced molecular characterization of enteropathogenic Escherichia coli isolated from diarrheic camel neonates in Egypt.
The study identified antibiotic resistance genes ampC, aadB, and mphA in E. coli isolates from diarrheic camel neonates in Egypt, indicating multidrug resistance.
Molecular Basis of AmpC beta-lactamase Induction by Avibactam in Pseudomonas aeruginosa: PBP Occupancy, Live Cell Binding Dynamics and Impact on Resistant Clinical Isolates Harboring PDC-X Variants.
The study investigated the molecular basis of AmpC beta-lactamase induction by avibactam in Pseudomonas aeruginosa, focusing on the relationship between PBP4 inhibition and ampC induction. It identified specific mutations in AmpC (E247K and DelG229-E247) that reduced susceptibility to avibactam and increased resistance to ceftolozane and ceftazidime.
Molecular Detection of Antibiotic Resistance Genes in Shiga Toxin-Producing E. coli Isolated from Different Sources.
The study identified multiple antibiotic resistance genes in Shiga toxin-producing E. coli (STEC) isolates, including aadA1, aac(3)-I, ere(A), ampC, blaSHV, blaCMY, and tet(A), which conferred resistance to various antibiotics such as streptomycin, gentamicin, erythromycin, ampicillin, penicillin, cephalosporin, and tetracycline.
Antimicrobial Resistance Profile and ExPEC Virulence Potential in Commensal Escherichia coli of Multiple Sources.
The study identified several AMR genes, including blaCTX-M, mcr-1, and qnrS1, which confer resistance to cephalosporins, colistin, and fluoroquinolones, respectively, in commensal E. coli from various sources.
AmpC beta-lactamase Variable Expression in Common Multidrug-Resistant Nosocomial Bacterial Pathogens from a Tertiary Hospital in Cairo, Egypt.
The study identified variable expression of the AmpC beta-lactamase gene in multidrug-resistant clinical isolates of Pseudomonas aeruginosa, Klebsiella pneumoniae, and Enterococcus faecium, contributing to resistance against β-lactam antibiotics.
The worldwide trend of Campylobacter spp., infection from duck-related isolates and associated phenotypic and genotypic antibiotic resistance, since 1985: identifying opportunities and challenges for prevention and control.
The study highlights the widespread presence of Campylobacter spp. in duck-related isolates and reports high resistance rates to fluoroquinolones, tetracycline, and other antibiotics. It emphasizes the need for improved surveillance and control measures to address antimicrobial resistance in Campylobacter.
Characterization of resistance mechanisms of Enterobacter cloacae Complex co-resistant to carbapenem and colistin.
The study identified blaKPC-2, blaNDM-1, mcr-4.3, ecr, ampC, blaCTX-M-14, blaCTX-M-9, blaSHV, and blaTEM as genes contributing to carbapenem and colistin resistance in Enterobacter cloacae Complex strains.
Cefiderocol Activity Against Clinical Pseudomonas aeruginosa Isolates Exhibiting Ceftolozane-Tazobactam Resistance.
Acquisition and loss of CTX-M plasmids in Shigella species associated with MSM transmission in the UK.
The study identifies the presence of bla CTX-M-27, erm(B), mph(A), aph(3')-Ib, aph(6)-Id, sul2, and tet(A) in Shigella isolates associated with MSM transmission in the UK, highlighting the role of plasmids in the spread of antimicrobial resistance.
Multiplication of ampC upon Exposure to a Beta-Lactam Antibiotic Results in a Transferable Transposon in Escherichia coli.
Exposure to amoxicillin leads to multiplication of the chromosomal ampC gene, resulting in a transferable transposon in E. coli. This transposon can be transferred between E. coli cells via transformation.
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model.
Prevalence and Antimicrobial Resistance Profiles of Foodborne Pathogens Isolated from Dairy Cattle and Poultry Manure Amended Farms in Northeastern Ohio, the United States.
The study identified several antimicrobial resistance genes in foodborne pathogens isolated from dairy cattle and poultry manure amended farms in Northeastern Ohio, including mphA, aadA, aphA1, tetA, aac(3)-IV, sulII, blaTEM, tetB, strA, aac(3)-Iva, ampC, lde, ermB, tet(O), aadB, penA, blaOXA-61, aadE, and aph-3-1.
AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications.
The study identified a mutation in ampD leading to hyperproduction of AmpC beta-lactamase in Cedecea davisae, resulting in resistance to beta-lactam antibiotics.
Hospital sink traps as a potential source of the emerging multidrug-resistant pathogen Cupriavidus pauculus: characterization and draft genome sequence of strain MF1.
The study identifies 12 antibiotic resistance genes in the draft genome of Cupriavidus pauculus strain MF1, including genes encoding beta-lactamases, efflux pumps, and a colistin resistance determinant. The isolate shows resistance to meropenem, amoxicillin, amikacin, gentamicin, and colistin, but susceptibility to cefotaxime, cefepime, imipenem, and ciprofloxacin.
Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007-19.
The study identified several AMR genes and mutations in ertapenem-non-susceptible Enterobacterales, including carbapenemases (NDM-5, OXA-181), beta-lactamases (TEM-1B, CTX-M-71), and mutations in PBP3 and porin genes (ompC, ompF) that contribute to resistance against cefepime/taniborbactam and other beta-lactam antibiotics.
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
The study evaluated the combination of flomoxef and fosfomycin for treating neonatal sepsis in settings with high antimicrobial resistance. It found that the combination showed synergy in bacterial killing and prevented the emergence of fosfomycin resistance. Specific AMR genes and mutations were identified in Enterobacterales strains, including beta-lactamases and efflux pumps.
Identification, Characterization, and Virulence Gene Expression of Marine Enterobacteria in the Upper Gulf of Thailand.
The study identified and characterized beta-lactamase genes (ampC, blaSHV, and blaTEM) in marine enterobacteria from the Upper Gulf of Thailand, highlighting their role in resistance to β-lactam antibiotics such as ampicillin and ticarcillin.
Genetic Resistance Determinants in Clinical Acinetobacter pittii Genomes.
The study identified various AMR genes and mutations in clinical Acinetobacter pittii strains, including aminoglycoside-modifying enzyme ant(3'')-IIa, beta-lactamases ampC and blaOXA-213, blaOXA-325, and blaOXA-58, as well as point mutations in gyrA, parC, pmrA, pmrB, and lpxA associated with resistance to ciprofloxacin and colistin.
Gram-Negative Rods on Inanimate Surfaces of Selected Hospital Facilities and Their Nosocomial Significance.
The study identified various AMR genes and mutations in gram-negative rods isolated from inanimate surfaces of hospital facilities, highlighting the presence of resistance mechanisms such as beta-lactamases, ESBLs, Qnr, OXA-48, and MBL.
Overproduction of Chromosomal ampC beta-lactamase Gene Maintains Resistance to Cefazolin in Escherichia coli Isolates.
The study shows that overproduction of the chromosomal ampC beta-lactamase gene maintains resistance to cefazolin in E. coli isolates, and mutations in the ampC attenuator regions contribute to this resistance.
Transmission of antibiotic resistance at the wildlife-livestock interface.
The study identifies the presence of antibiotic resistance genes such as ampC and acrA in feral swine, cattle, soil, and water samples, highlighting the potential transmission of antibiotic resistance at the wildlife-livestock interface.
Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance.
The paper reviews mechanisms of cefiderocol resistance, highlighting the roles of beta-lactamases (NDM, KPC, OXA-427, PER, SHV, BEL, AmpC), mutations in siderophore receptors (piuA, piuD, pirA, cirA, fiu), porins (ompK35, ompK36, ompK37, ompC, ompF), efflux pumps (mexAB-oprM, smeDEF, axyABM), and target modifications (pbp3).
Evolution of Habitat-Dependent Antibiotic Resistance in Pseudomonas aeruginosa.
The study identifies various genes and mutations associated with resistance to tobramycin, ceftazidime, and ceftazidime-avibactam in Pseudomonas aeruginosa, highlighting the impact of environmental conditions on the evolution of antibiotic resistance.
Metabolic phenotyping of acquired ampicillin resistance using microbial volatiles from Escherichia coli cultures.
The study identifies the ampC gene as responsible for ampicillin resistance in E. coli, demonstrating that the AmpC-producing strain exhibits distinct volatile organic compound (VOC) profiles compared to the susceptible strain.
A Selective Medium for Screening Ceftazidime/Avibactam Resistance in Carbapenem-Resistant Enterobacterales.
The study developed an SS CZA medium for screening CZA-resistant CRE isolates, demonstrating 100% sensitivity and specificity. The medium effectively distinguishes between CZA-resistant and -susceptible strains, with resistance determinants including blaNDM, blaKPC, blaCTX-M, blaTEM, blaSHV, blaOXA-23, blaIMP, and ampC.
Molecular characterization and biofilm-formation analysis of Listeria monocytogenes, Salmonella spp., and Escherichia coli isolated from Brazilian swine slaughterhouses.
The study identified various antimicrobial resistance genes in E. coli and Salmonella Typhi isolates from Brazilian swine slaughterhouses, including ampC, blaSHV, cat1, clmA, MCR-1, MCR-3, tet(A), tet(B), tet(C), tet(M), and sulI. These genes conferred resistance to multiple antibiotics such as ampicillin, amoxicillin, chloramphenicol, tetracycline, doxycycline, colistin, and sulfonamide.
Environmental complexity is more important than mutation in driving the evolution of latent novel traits in E. coli.
Complex antibiotic environments drive the evolution of latent novel traits in E. coli through the spread of pleiotropic mutations affecting multiple resistance mechanisms.
Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC beta-lactamases in Pseudomonas aeruginosa.
The study shows that the enzymatic activity of AmpC beta-lactamase is essential for the full virulence attenuation in Pseudomonas aeruginosa under peptidoglycan recycling impairment, while the biological cost of AmpC variants is similar to the wild-type enzyme.
Draft Genome Sequences of Multidrug-Resistant Escherichia coli Isolated from River Water.
The study reports the draft genome sequences of seven multidrug-resistant Escherichia coli strains isolated from river water, identifying various antibiotic resistance genes and mutations associated with resistance to multiple antibiotics.
Mobile genetic elements in Acinetobacter antibiotic-resistance acquisition and dissemination.
The study highlights the role of mobile genetic elements, particularly insertion sequences (IS), in the acquisition and dissemination of antibiotic resistance in Acinetobacter species. IS elements can enhance the expression of intrinsic beta-lactamase genes, such as bla OXA-23, bla OXA-51, and ampC, leading to carbapenem and cephalosporin resistance. Additionally, IS elements can disrupt genes involved in antibiotic uptake, such as porins, and alter the expression of efflux pumps, contributing to multidrug resistance.
The first outbreak of citrobacteriosis caused by Citrobacter gillenii in reared Russian sturgeon (Acipenser gueldenstaedtii) in Turkiye.
Citrobacter gillenii was identified as the causative agent of a fatal bacterial disease in Russian sturgeon. Resistance genes ampC, sul1, and floR were detected, conferring resistance to penicillin, trimethoprim/sulfamethoxazole, and florfenicol, respectively.
Incidence of antibiotic resistance genotypes of Vibrio species recovered from selected freshwaters in Southwest Nigeria.
The study identified multiple antibiotic resistance genes in Vibrio species from freshwater samples in Southwest Nigeria, including sulI, sulII, ampC, blaOXA, blaPSE, tetA, tetE, strA, aacC2, and aphA1, highlighting the environmental spread of resistance genes.
Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence.
The study identified that a single mutation in the ampC gene led to CAZ-AVI resistance in XDR P. aeruginosa, highlighting the importance of maintaining adequate drug concentrations to prevent resistance development.
Validation and Application of Long-Read Whole-Genome Sequencing for Antimicrobial Resistance Gene Detection and Antimicrobial Susceptibility Testing.
The study validated the use of long-read whole-genome sequencing for detecting antimicrobial resistance genes and predicting antimicrobial susceptibility. Several beta-lactamase and carbapenemase genes were identified in various bacterial isolates, demonstrating their role in resistance to specific antibiotics.
Differential response to prolonged amoxicillin treatment: long-term resilience of the microbiome versus long-lasting perturbations in the gut resistome.
The study found that prolonged amoxicillin treatment leads to an increase in the abundance and diversity of antimicrobial resistance genes (ARGs) in the gut microbiome, particularly beta-lactamase genes such as cfxA and its variants, as well as tetracycline and macrolide resistance genes.
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa.
Mutations in the ampC gene of Pseudomonas aeruginosa enhance resistance to ceftolozane/tazobactam but reduce resistance to imipenem, leading to collateral susceptibility.
Transcriptional profiling of Pseudomonas aeruginosa mature single- and dual-species biofilms in response to meropenem.
The study found that the beta-lactamase gene ampC is significantly upregulated in P. aeruginosa single-species biofilms in response to meropenem, indicating its role in carbapenem resistance.
The E. coli pathobiont LF82 encodes a unique variant of σ(70) that results in specific gene expression changes and altered phenotypes.
The rpoD D445V mutation in E. coli LF82 leads to increased β-lactam resistance, altered gene expression, and changes in phenotypes such as biofilm formation and motility.
Antimicrobial Resistance in Salmonella from Food-Producing Animals and Carcases
The report highlights the presence of carbapenemase-producing E. coli isolates carrying bla OXA-48, bla OXA-181, and bla NDM-5 genes in pigs, bovines, and meat, indicating the need for continued monitoring and follow-up.
YgfB increases β-lactam resistance in Pseudomonas aeruginosa by counteracting AlpA-mediated ampDh3 expression.
YgfB increases β-lactam resistance in Pseudomonas aeruginosa by repressing ampDh3 expression, which in turn affects AmpC beta-lactamase levels and resistance.
Whole-cell modeling of E. coli colonies enables quantification of single-cell heterogeneity in antibiotic responses.
The study identifies ampC as a key beta-lactamase gene involved in ampicillin resistance in E. coli, highlighting its sub-generational expression and role in cellular heterogeneity in antibiotic responses.
The Role of Hypermutation and Collateral Sensitivity in Antimicrobial Resistance Diversity of Pseudomonas aeruginosa Populations in Cystic Fibrosis Lung Infection.
The study identifies several genes and mutations associated with antimicrobial resistance in Pseudomonas aeruginosa populations from cystic fibrosis patients, including ampC, mexB, norM, gyrA, and mutations in mutS and mutL.
Social demographics determinants for resistome and microbiome variation of a multiethnic community in Southern Malaysia.
The study identified 1038 antibiotic resistance genes from 200 community participants, highlighting the association of resistome profiles with lifestyle and environmental factors, particularly emphasizing the role of Escherichia coli in the resistome dynamics.
Antimicrobial Resistance and Biofilm Formation of Escherichia coli Isolated from Pig Farms and Surroundings in Bulgaria.
The study identified the presence of beta-lactamase-producing genes ampC and blaTEM in E. coli isolates from pig farms in Bulgaria, indicating resistance to penicillins.
Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment.
This review discusses the molecular basis of challenges to effective treatment of UPEC-associated urinary tract infections, focusing on virulence factors and antibiotic resistance mechanisms.
Proteomic analysis of ceftazidime and meropenem-exposed Pseudomonas aeruginosa ATCC 9027.
The study identified ampC, oprD, mexA, and mexB as key genes involved in the resistance of Pseudomonas aeruginosa to ceftazidime and meropenem through proteomic analysis and qRT-PCR validation.
Antibiotic-induced reactive oxygen species promote de novo acquisition of antimicrobial resistance
The study shows that exposure to sublethal concentrations of antibiotics increases reactive oxygen species (ROS), which promotes the de novo acquisition of antimicrobial resistance. Amplification of the chromosomal ampC gene was observed in E. coli and L. lactis under various antibiotic treatments, suggesting a potential mechanism for resistance development.
Genetic determinants underlying the progressive phenotype of β-lactam/beta-lactamase inhibitor resistance in Escherichia coli.
The balance between antibiotic resistance and fitness/virulence in Pseudomonas aeruginosa: an update on basic knowledge and fundamental research.
The paper discusses the relationship between antibiotic resistance and bacterial fitness/virulence in Pseudomonas aeruginosa, focusing on horizontally-acquired and mutation-driven resistance mechanisms. It highlights that certain beta-lactamases and the mcr-1 gene can confer resistance without significant fitness costs, while others may lead to virulence attenuation.
DNA supercoiling and regulation of intrinsic beta-lactamase in pathogenic Escherichia coli.
The study highlights the role of DNA supercoiling in the regulation of intrinsic beta-lactamase (ampC) in pathogenic Escherichia coli, emphasizing the impact of promoter and attenuator mutations on ampC expression and β-lactam resistance.
Divergent genetic landscapes drive lower levels of AmpC induction and stable de-repression in Serratia marcescens compared to Enterobacter cloacae.
The study identifies that the AmpC beta-lactamase in Enterobacter cloacae exhibits higher hydrolytic efficiency for ceftriaxone compared to Serratia marcescens, contributing to higher ceftriaxone resistance levels in E. cloacae. Additionally, E. cloacae shows greater ampC transcript levels upon de-repression, further enhancing resistance.
In Vitro Microevolution and Co-Selection Assessment of Florfenicol Impact on Escherichia coli Resistance Development.
Florfenicol exposure leads to increased resistance to fluoroquinolones and cephalosporins through mutations in efflux pump genes such as acrB, acrR, emrR, and robA, as well as the presence of resistance genes like ampC, ampH, bacA, and emrB.
Resistance mechanism of Escherichia coli strains with different ampicillin resistance levels.
The study identified mutations in several genes, including ampC, murE, ftsI, marR, gutQ, rpoC, dcuA, frdD, and amiB, which contribute to ampicillin resistance in E. coli strains. The ampC promoter mutation was found to significantly increase ampC gene expression and ampicillin resistance.
Filling knowledge gaps related to AmpC-dependent β-lactam resistance in Enterobacter cloacae.
The study investigated the role of ECL_03254, a putative AmpC-type beta-lactamase, in Enterobacter cloacae. Despite high expression, it did not significantly increase resistance to cephalosporins. The primary AmpC gene ECL_00553 was found to confer resistance to cefoxitin and cefotaxime.
Phenotypic Detection of Carbapenemase and AmpC-β-Lactamase Production among Extended Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella spp. Isolated from Clinical Specimens.
The study identified NDM, OXA-48-like, and VIM carbapenemases, as well as AmpC-beta-lactamases, in ESBL-producing E. coli and Klebsiella spp. isolates from Burkina Faso, highlighting the presence of multidrug-resistant pathogens across healthcare levels.
Antibiotic resistance and virulence profiles of Proteus mirabilis isolated from broiler chickens at abattoir in South Africa.
The study identified multiple antibiotic resistance genes in Proteus mirabilis isolates from broiler chickens, including bla CTX-M, bla TEM, qnrA, qnrD, mcr-1, catI, catII, and ampC, highlighting the presence of multidrug-resistant strains and extended-spectrum beta-lactamase-producing isolates.
Whole genome sequence-based molecular characterization of blood isolates of carbapenem-resistant Enterobacter cloacae complex from ICU patients in Kolkata, India, during 2017-2022: emergence of phylogenetically heterogeneous Enterobacter hormaechei subsp. xiangfangensis.
The study identified several carbapenemase and extended-spectrum beta-lactamase genes, including bla NDM-1, bla NDM-4, bla NDM-5, bla NDM-7, bla OXA-181, bla OXA-232, bla KPC-3, bla CTX-M-15, bla SFO-1, bla ACT, and bla CMH-3, in carbapenem-resistant Enterobacter cloacae complex isolates from Kolkata, India. Novel integrons (In180, In4874, In4887, and In4888) were also discovered.
Community Emergence of Cefixime-Resistant Escherichia coli Belonging to ST12 with Chromosomal AmpC Hyperproduction.
The study identifies a chromosomal AmpC hyperproduction mechanism in cefixime-resistant E. coli ST12 isolates, linked to a promoter mutation at position -32 (T > A), resulting in resistance to several beta-lactam antibiotics.
In Vitro Microevolution and Co-Selection Assessment of Amoxicillin and Cefotaxime Impact on Escherichia coli Resistance Development.
Clinical Presentation, Antimicrobial Resistance, and Treatment Outcomes of Aeromonas Human Infections: A 14-Year Retrospective Study and Comparative Genomics of 2 Isolates From Fatal Cases.
The study identified multiple antimicrobial resistance (AMR) genes, including bla OXA, ampC, cphA, and mcr-3, in Aeromonas dhakensis isolates from fatal cases. These genes conferred resistance to carbapenems, piperacillin-tazobactam, and colistin.
Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection.
The study characterizes various AMR genes and mutations in Enterobacterales and Pseudomonas aeruginosa, including bla CTX-M-15, bla OXA-1, bla OXA-181, bla OXA-48, bla NDM-1, bla KPC-3, bla VIM-2, ampC, cmrA, mexAB-OprM, mexXY-OprM, oprD, ompK35, ompK36, and ftsI, which confer resistance to cefepime and carbapenems.
A Label-Free Droplet Sorting Platform Integrating Dielectrophoretic Separation for Estimating Bacterial Antimicrobial Resistance.
The study developed a label-free dielectrophoresis-based microfluidic platform to estimate antimicrobial resistance in bacteria. The platform sorts droplets containing ampicillin-sensitive and ampicillin-resistant E. coli based on differences in conductivity caused by bacterial growth and antibiotic effects.
Detection of Salmonella Pathogenicity Islands and Antimicrobial-Resistant Genes in Salmonella enterica Serovars Enteritidis and Typhimurium Isolated from Broiler Chickens.
The study identified several antimicrobial-resistant genes in Salmonella enterica serovars Enteritidis and Typhimurium isolated from broiler chickens, including tet(K), tet(O), tet(A), mcr-1, mcr-4, strA, strB, aadA, aadE, sulI, ampC, TEM, CTX-M, and OXA. These genes conferred resistance to tetracycline, colistin, aminoglycosides, sulfonamides, and beta-lactam antibiotics.
Widespread prevalence of plasmid-mediated blaCTX-M type extended-spectrum beta-lactamase Escherichia coli in backyard broiler production systems in the United States.
The study identified blaCTX-M type extended-spectrum beta-lactamase (ESBL) Escherichia coli in backyard broiler production systems in the United States, with a higher prevalence in backyard farms compared to commercial farms. The most common blaCTX-M variants were blaCTX-M-1, blaCTX-M-55, and blaCTX-M-65. Resistance to cefepime, a fourth-generation cephalosporin, was also observed.
Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa genomes.
The study presents an updated Pseudomonas aeruginosa AMR database and evaluates the performance of various AMR prediction tools, highlighting the importance of chromosomal variants in improving AMR detection accuracy.
Impact of extended-spectrum chromosomal AmpC (ESAC) of Escherichia coli on susceptibility to cefiderocol.
Extended-spectrum chromosomal AmpC (ESAC) beta-lactamases in Escherichia coli confer resistance to ceftazidime, decrease susceptibility to cefepime, and also act on cefiderocol, reducing its effectiveness.
Beta-lactamase dependent and independent evolutionary paths to high-level ampicillin resistance.
The study identifies ampC beta-lactamase and multiple mutations in genes involved in multidrug resistance, transcriptional regulation, and membrane processes as key contributors to high-level ampicillin resistance in E. coli.
Prevalence of multidrug-resistant Escherichia coli isolates and virulence gene expression in poultry farms in Jos, Nigeria.
The study identified multidrug-resistant Escherichia coli isolates in poultry farms in Jos, Nigeria, with resistance genes including tetA, gyrA, sul1, and ampC.
Characterization of the carbapenem-resistant Acinetobacter baumannii clinical reference isolate BAL062 (CC2:KL58:OCL1): resistance properties and capsular polysaccharide structure.
The study characterizes the carbapenem-resistant Acinetobacter baumannii isolate BAL062, identifying resistance genes such as oxa23, ampC, strA-strB, tet(B), sul1, aadA1, and aacC1. It also reveals that BAL062 has lost certain resistance genes, resulting in susceptibility to amikacin, tobramycin, and kanamycin.
Transcriptomic Analyses to Unravel Cronobacter sakazakii Resistance Pathways.
The study identifies several AMR genes in Cronobacter sakazakii, including ampC, b1256, Z2647, ACIAD3023, gstA, MarB, BsmA, PhoP, ramA, b1526, b4189, SF1149, DUF2724, T1E_0241, B1243, Arnit_2199, ECP_0940, ML0773, and ampC, which are associated with resistance to various antibiotics such as penicillins, aminoglycosides, tetracyclines, fluoroquinolones, and cephalosporins.
Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22.
Cefepime-taniborbactam showed potent in vitro activity against Enterobacterales and P. aeruginosa, particularly effective against isolates with carbapenemase genes such as blaIMP, blaNDM, and blaVIM, as well as those with mutations in ftsI, ompK35, and ompK36.
Evaluation of an expanded antibiotic resistance gene panel on prediction of antimicrobial susceptibility results for Gram-negative bacteria in blood cultures.
The study evaluated the QIAstat-Dx BCID panel for detecting antibiotic resistance genes in Gram-negative bacteria from blood cultures. It found that the panel effectively identified several resistance genes, including bla CTX-M, bla KPC, bla NDM, and others, which are crucial for predicting antimicrobial susceptibility. The panel showed high sensitivity and specificity for identifying resistance genes and predicting susceptibility, especially for beta-lactam antibiotics.
Molecular characterization, virulence and antimicrobial and biocidal susceptibility of selected bacteria isolated from the cloaca of nestling ospreys (Pandion haliaetus) from Mono Lake, California, USA.
The study identified several AMR genes and mutations in bacteria isolated from the cloaca of nestling ospreys, including bla CTX-M-55, bla EC, tet (A), floR, sul3, dfrA14, aac(3)-IIa, ampC, fosA5, sal (A), blaZ, tet (M), and pbp5. Mutations in gyrA, parC, parE, ompK36, ompK37, rpoB, and pbp5 were also detected, contributing to resistance against various antibiotics.
Monitoring of Pseudomonas aeruginosa mutational resistome dynamics using an enrichment panel for direct sequencing of clinical samples.
The study presents a hybridisation-based capture system for the enrichment of genes related to P. aeruginosa antimicrobial resistance, allowing the direct sequencing of clinical samples. The panel successfully identified key resistance mutations, including ampC-T96I, oprD-Q142X, mexZ-G195D, gyrA-T83I, gyrA-D87N, parC-S87W, ampR-G154R, and others, demonstrating its effectiveness in detecting resistance mechanisms in various clinical scenarios.
Longitudinal genomics reveals carbapenem-resistant Acinetobacter baumannii population changes with emergence of highly resistant ST164 clone.
The study identifies the emergence of the highly resistant ST164 clone of Acinetobacter baumannii in an ICU setting, highlighting the presence of multiple carbapenemase genes including bla OXA-23, bla NDM-1, bla CARB-16, and ampC.
Myroides species, pathogenic spectrum and clinical microbiology sight in Mexican isolates.
The study identified multiple AMR genes in Myroides spp. isolates, including beta-lactamases (blaIMP-27, blaIMP-35, blaGOB-16, blaMUS-1, blaOXA-229, blaOXA-351, blaOXA-97), erythromycin esterase (ereB), and polymyxin resistance genes (mcr-3.6, mcr-3.7, mcr-3.10), indicating a high level of multidrug resistance.
In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC beta-lactamase in Klebsiella aerogenes.
The study describes the in vivo emergence of resistance to ceftazidime/avibactam through modification of the chromosomal AmpC beta-lactamase in a clinical isolate of Klebsiella aerogenes. A mutation (R148W) in the AmpC gene was identified, which led to high-level resistance to ceftazidime/avibactam and cefepime.
Evaluation of the QIAstat-Dx BCID GN and GPF kits for direct identification and antimicrobial resistance prediction from blood culture bottles.
The QIAstat-Dx BCID GN and GPF kits showed high accuracy in detecting AMR genes such as blaZ, mecA, ermC, aac(6')-lb, ctx-m, ampC, shv, tem, tetM, and aac(6')/aph(2") in various bacteria, correlating well with phenotypic resistance results.
In vivo divergent evolution of cross-resistance to new β-lactam/β-lactamase inhibitor combinations in Pseudomonas aeruginosa following ceftazidime/avibactam treatment.
The study identifies bla PDC−575, a novel beta-lactamase, and ampC overexpression as critical mechanisms for resistance to ceftazidime/avibactam and ceftolozane/tazobactam in Pseudomonas aeruginosa. Additionally, dacB mutation contributes to resistance.
Antimicrobial resistance, virulence genes profiles and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae strains from captive giant pandas (Ailuropoda melanoleuca).
The study identified multiple antibiotic resistance genes (ARGs) in carbapenem-resistant Klebsiella pneumoniae (CRKP) strains isolated from captive giant pandas, including aac C, bla CTX−M−04, bla OXY, bla SHV−01, bla SHV−02, amp C /bla DHA, tet B−01, tet B−02, tet C−01, tet C−02, and van TC−02. These genes were found to confer resistance to various antibiotics, highlighting the complexity of antimicrobial resistance in these strains.
Distinct molecular epidemiology of resistances to extended-spectrum cephalosporins and carbapenems in Enterobacter hormaechei in cats and dogs versus horses in France.
The study identified distinct molecular epidemiology of resistances to extended-spectrum cephalosporins and carbapenems in Enterobacter hormaechei from cats, dogs, and horses in France, highlighting the role of specific resistance genes such as bla SHV-12, bla CTX-M-15, and bla OXA-48, along with ampC overexpression and rmtB/armA-mediated aminoglycoside resistance.
Progression of ampC amplification during de novo amoxicillin resistance development in E. coli.
Risk assessment and photo-disinfection of antibiotic residues and antibiotic-resistant bacteria in water sources from Ede, Nigeria.
The study identified antibiotic residues and antibiotic-resistant bacteria (ARB) in various water sources in Ede, Nigeria, highlighting the presence of multidrug-resistant (MDR) bacteria such as Bacillus spp. and Staphylococcus. It also assessed the ecological and health risks associated with these residues and proposed a photocatalytic material for water disinfection.
Machine Learning-Based Detection of Heteroresistance to Piperacillin/Tazobactam in Escherichia coli
The study identifies beta-lactamase genes (blaTEM, blaCTX, blaSHV, ampC) as strong predictors of heteroresistance in E. coli, with the number of these genes correlating with resistance levels.
Eradication of Helicobacter pylori reshapes gut microbiota and facilitates the evolution of antimicrobial resistance through gene transfer and genomic mutations in the gut.
H. pylori eradication led to the enrichment of various AMR genes, including beta-lactamases, macrolide phosphotransferases, erythromycin ribosome methyltransferases, sulfonamide resistance proteins, tetracycline efflux pumps, dihydrofolate reductase, quaternary ammonium compound efflux pumps, and aminoglycoside phosphotransferases. Additionally, genomic mutations in parC, parE, and gyrA were associated with fluoroquinolone resistance in E. coli.
Mutant prevention concentrations and phenotypic and genomic profiling of first-step resistance mechanisms to classical and novel β-lactams in Pseudomonas aeruginosa.
Isolation, Identification, and Characteristics of Aeromonas salmonicida subsp. masoucida from Diseased Starry Flounder (Platichthys stellatus).
The study identified 11 antimicrobial resistance genes in Aeromonas salmonicida subsp. masoucida strains isolated from diseased starry flounders, including genes conferring resistance to beta-lactams, tetracyclines, sulfonamides, chloramphenicol, and biocides.
Antibiotic Resistance and Virulence Determinants of Pseudomonas aeruginosa Isolates Cultured from Hydrocarbon-Contaminated Environmental Samples.
Detection of Antibiotic-Resistance Genes in Drinking Water: A Study at a University in the Peruvian Amazon.
The study detected the presence of antibiotic-resistance genes (ermC, amp, QEP, marA, and qEmarA) in all water samples analyzed, highlighting the widespread dissemination of resistance factors in drinking water.
Multi-omics profiling of cross-resistance between ceftazidime-avibactam and meropenem identifies common and strain-specific mechanisms in Pseudomonas aeruginosa clinical isolates.
The study identified several genes and mutations associated with resistance to ceftazidime-avibactam (CZA) and meropenem (MEM) in Pseudomonas aeruginosa, including dacB, ftsI, oprD, mexB, mexR, and ampC. Mutations in these genes were linked to resistance mechanisms, and CRISPR-Cas9 experiments confirmed the role of certain mutations in altering resistance levels.
Nationwide surveillance of carbapenem-resistant Gram-negative pathogens in the Lebanese environment.
The study identified carbapenem-resistant Gram-negative bacteria in various environmental samples in Lebanon, including Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. Key resistance genes detected include bla NDM-5, bla OXA-23, bla OXA-66, mexAB-OprM, bla IMP-1, and others, highlighting the widespread presence of carbapenem resistance in the environment.
Mutations in ampD cause hyperproduction of AmpC and CmcB beta-lactamases and high resistance to β-lactam antibiotics in Chromobacterium violaceum.
Mutations in the ampD1 gene of Chromobacterium violaceum lead to hyperproduction of AmpC and CmcB beta-lactamases, resulting in high resistance to β-lactam antibiotics.
Phenotypic and Genotypic Characterization of ESBL and AmpC beta-lactamase-Producing E. coli Isolates from Poultry in Northwestern Romania.
The study identified the presence of ESBL and AmpC beta-lactamase-producing E. coli isolates from poultry in northwestern Romania, highlighting the prevalence of resistance genes blaTEM, blaZ, and AmpC, which contribute to resistance against β-lactam antibiotics.
Fast evolution of SOS-independent multi-drug resistance in bacteria.
The study identifies ampC and acrB mutations as key contributors to β-lactam resistance in E. coli lacking RecA, highlighting a novel SOS-independent resistance mechanism.
An antisense peptide-conjugated peptide nucleic acid (PPNA) for peptidoglycan recycling inhibition reduces AmpC hyperproduction and β-lactam resistance in Pseudomonas aeruginosa.
The study shows that targeting nagZ with a PPNA reduces AmpC hyperproduction and β-lactam resistance in Pseudomonas aeruginosa, demonstrating the potential of antisense strategies to restore antibiotic susceptibility.
Epidemiology of potential source, risk attribution of Clostridium perfringens from Egyptian broiler farms and genetic diversity of multidrug resistance strains.
The study identified multiple AMR genes in Clostridium perfringens isolates from Egyptian broiler farms, including aminoglycoside, beta-lactam, macrolide, quinolone, sulfonamide, tetracycline, and trimethoprim resistance genes. High prevalence of multidrug-resistant strains was observed.
Minimal gene signatures enable high-accuracy prediction of antibiotic resistance in Pseudomonas aeruginosa.
The study identifies minimal gene signatures for high-accuracy prediction of antibiotic resistance in Pseudomonas aeruginosa, highlighting the role of efflux pumps, metabolic adaptations, and porin alterations in resistance mechanisms.
In vitro antimicrobial activity and resistance mechanisms of cefiderocol against clinical carbapenem-resistant gram-negative bacteria.
Cefiderocol showed high in vitro activity against carbapenem-resistant gram-negative bacteria, with resistance mechanisms involving beta-lactamase genes (bla OXA-66, bla OXA-23, bla SHV-12), mutations in envZ, cirA, nuoC, and ampC, and loss or altered expression of iron transporter genes (piuA, pirA, fepA).
Disruption of undecaprenyl phosphate recycling suppresses ampC beta-lactamase induction in Pseudomonas aeruginosa.
Deletion of dedA4 in Pseudomonas aeruginosa reduces AmpC production and beta-lactam resistance by altering the balance of peptidoglycan precursors and recycling products, affecting AmpR activity.
Target-Based Biofilm Inhibition and Antibiotic Enhancement Strategy by MiR.101.3p Using DNA Tetrahedrons.
The study identifies that miR.101.3p targets ampC, fleN, and pslK genes in P. aeruginosa, reducing biofilm formation and enhancing cefotaxime efficacy.
Myco- and microbiological profiling of a human cadaver reveals drug-resistant strains and new fungal records.
The study identified drug-resistant fungal and bacterial isolates from a human cadaver, including new fungal records and species with potential pathogenicity. Antimicrobial susceptibility testing revealed resistance to antifungal agents like voriconazole and amphotericin B, as well as to various antibiotics.
Resistance evolution under potentiated sulphonamide pressure in Escherichia coli.
The study identified multiple antimicrobial resistance genes and mutations in E. coli under potentiated sulphonamide pressure, highlighting the role of efflux pumps and folate pathway modifications in resistance development.
Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens.
The paper reviews molecular resistance mechanisms to newly approved antibiotics in WHO priority pathogens, identifying various beta-lactamases, efflux pumps, and target site modifications that confer resistance.
No comments yet. Be the first to comment!